anonymous
Guest
anonymous
Guest
First, you flood oncology offices with a bunch of overpaid, whiny, cry-baby primary care reps that "close for the next 10 patients" on every call. Then you establish stupid "call average" metrics. Again, a primary care tactic that does not work in oncology. Then you stoop to a new low---you start doing direct-to-consumer advertising on a niche oncology lung cancer drug. The problem with this is the commercial gives an impression of false hope. Sure, you may extend life after you scare the crap out of them with all those side effects. But this is about as cheap as attorney's advertising. Why don't you guys sponsor the Jerry Springer show if you are going to do this? Just sick and sad.
Now, you are leaking data that Metformin (the pancreas killer) might be an anti-aging drug in hopes of driving off-label sales. Weren't you guys operating under a FTC/FDA Corporate Intelligence Agreement? Did you not gain any "intelligence" while on that agreement? I hope the FDA comes down hard on this. You are destroying any last ounce of integrity pharma might have. Sad to see you guys ruin it for everyone.
And stop telling accounts that all staff appears on the Sunshine Act report. That is not the case and if you are reporting staff on that, you are going to really have some enemies.
Now, you are leaking data that Metformin (the pancreas killer) might be an anti-aging drug in hopes of driving off-label sales. Weren't you guys operating under a FTC/FDA Corporate Intelligence Agreement? Did you not gain any "intelligence" while on that agreement? I hope the FDA comes down hard on this. You are destroying any last ounce of integrity pharma might have. Sad to see you guys ruin it for everyone.
And stop telling accounts that all staff appears on the Sunshine Act report. That is not the case and if you are reporting staff on that, you are going to really have some enemies.